Sushmita Lahiri

Sushmita Lahiri is currently the Associate Vice President and Global Project Head at Sanofi.34 She has an extensive background in pharmaceutical research and development, particularly in the field of infectious diseases and antibacterial discovery.

Professional Experience

Prior to her role at Sanofi, Lahiri held several notable positions:

• Global Head of Antibacterial Discovery at Johnson & Johnson, USA, where she led the preclinical development team responsible for optimization, nomination, and support for clinical candidates.1
• Member of the External Innovation team at Boehringer Ingelheim, focusing on emerging science and technologies in gene therapy, regenerative medicine, microbiomes, and infectious diseases.1
• Executive Director at Macrolide Pharmaceuticals, a biotechnology company developing novel synthetic macrolides for Gram-negative pathogens.12
• Researcher at AstraZeneca's Infectious Diseases division in Boston, USA, for over a decade.1

Education and Expertise

Lahiri's educational background includes:

• PhD in Cell and Molecular Biology from Boston University School of Medicine (2004).14
• Master's degree in Biochemistry from the University of Nebraska (1999).1

Her expertise spans various areas of drug discovery and development, including:

• Antibacterial compounds
• β-lactamase inhibition
• Bacterial resistance mechanisms
• Preclinical microbiological and pharmacological studies

Achievements and Contributions

Throughout her career, Lahiri has made significant contributions to the field:

• Co-authored over 45 publications in peer-reviewed journals.1
• Served on review panels for anti-infective grants, including CARB-X and NIH SBIR and BAA study sections.1
• Contributed to the development of several important antibacterial compounds, including avibactam, ceftazidime-avibactam, and ceftaroline fosamil.1

Sushmita Lahiri's LinkedIn profile can be found under the username sushmita-lahiri-0381012.4